NCT05579639View on ClinicalTrials.gov

Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

PHASE2RecruitingINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2027

Conditions
Allogeneic Stem Cell Transplantation
Interventions
OTHER

Xylitol

Xylitol wipes

OTHER

Placebo

Placebo wipes

Trial Locations (3)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

80045

RECRUITING

Children's Hospital Colorado, Aurora

02115

RECRUITING

Dana-Farber/Boston Children's, Boston

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER